Maxim analyst Jason McCarthy downgraded Antibe Therapeutics to Hold from Buy, stating that an unfavorable arbitration ruling likely delays clinical operations and makes the path forward “unclear.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ATBPF: